PCOS Awareness within Community Areas

PCOS Relief fights stigma in minority communities by educating women about PCOS & providing support with respect and privacy

One of PCOC Relief’s purposes is to promote Equality and Diversity, therefore it is crucial we raise awareness of PCOS within Ethnic Minority communities.

We understand there is already a huge amount of stigma when talking about Women’s Health in general within certain communities, therefore we want to support individuals by educating them about this condition and raising awareness, also allowing the individual to know where and how to access support in confidence.

We aim to provide reassurance, that every female who is apart of PCOS Relief will be treated with dignity and respect and trust that all their details and information will be treated as private and confidence.

Our approach to any community is not to over-step any boundaries as we understand, Women Health is a sensitive and private conversation, however, our approach is only to provide awareness, support, guidance, information, and our services.

This condition is a long term health condition, which currently does not have a cure or cause, therefore, we need to support every female despite their background and break the stigma

Avatar photoAvatar photoAvatar photo

Seeking Support? Start Your PCOS Journey Now

Explore a wealth of resources and a supportive community dedicated to empowering you on your PCOS journey. Join us today.
Official update · May 2026

A landmark update
for 170 million
women worldwide

Previously PCOS Polycystic Ovary Syndrome
Now officially PMOS Polyendocrine Metabolic Ovarian Syndrome

Published in The Lancet, May 2026 · Endorsed by the Endocrine Society · 56 global organisations

What was PCOS?

A hormonal condition named after the appearance of follicles on the ovaries — a term widely recognised as inaccurate, leading to delayed diagnoses and misunderstood care for millions.

What is PMOS?

A complex, long-term condition involving multiple hormone imbalances, metabolic effects like insulin resistance, and impacts on reproductive, mental, and cardiovascular health — far beyond just the ovaries.

After a decade-long global study with 22,000+ patients and clinicians, the new name was published in The Lancet to reduce diagnostic delays affecting up to 70% of women living with this condition.

Take Survey